Table 4.
Number (%) of patients with adverse event | ||
Adverse event | Rosuvastatin (n = 233) | Atorvastatin (n = 236) |
Nasopharyngitis | 23 (9.9) | 19 (8.1) |
Myalgia | 13 (5.6) | 7 (3.0) |
Inadequately controlled diabetes mellitus | 14 (6.0) | 11 (4.6) |
Constipation | 9 (3.9) | 6 (2.5) |
Headache | 6 (2.6) | 7 (3.0) |
Urinary tract infection | 9 (3.9) | 2 (0.9) |
Arthralgia | 1 (0.4) | 9 (3.8) |